This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
ISPAD Prize of Achievement 2019

Georgeanna J. Klingensmith, MD; Professor Emerita, Pediatrics, University of Colorado School of Medicine

has won the ISPAD Prize of Achievement for 2019

Dr. Klingensmith’s major focus of study has been the epidemiology and outcomes of care in type 1 diabetes beginning in the 1980s with the Colorado Diabetes Registry which expanded into the national SEARCH for Diabetes study. SEARCH documented the increasing rate of both type 1 and type 2 diabetes in children <20 in the US. She has been especially interested in studies that provide US benchmark data for diabetes care and she has highlighted ethnic and racial disparities in T1D care and outcomes, first in SEARCH and then in the T1D Exchange. She has explored many aspects of diabetes care and outcomes including the importance of quality of life and behavioral health in children and their parents. She also participated in epidemiology and outcome studies of type 2 diabetes in youth, both in SEARCH and as a co-investigator for the TODAY trial. She is now the Vice-Chair of the Pediatric Diabetes Consortium, a 60-center consortium focused on completing trials of newer medications for FDA and EMA approval to provide better therapeutic options for adolescents with T2D.   


Dr. Klingensmith has been a co-investigator in the BDC DAISY study. DAISY was one of the first studies to evaluate risk factors for autoimmunity and for progression to T1D in children in the general population and those with a family member with T1D. The DAISY study, along with BabyDiab and DIPP, documented that once two diabetes autoantibodies develop, progression to T1D is inevitable, regardless of family history, opening immune-intervention trials to more participants.   


For over 20 years Dr. Klingensmith’s passion has been training fellows and junior faculty in pediatric endocrinology. She has been the PI for NIH funded K12 and T32 awards to train faculty and fellows in diabetes research and leadership skills. Her mentees are taking their place at all academic ranks as the new leaders in academic medicine. They have become endocrinology section heads and excellent mentors themselves, a sure measure of her success in developing the leaders of today and tomorrow.


She has been a member of the editorial and the writing committees for multiple American Diabetes Association and ISPAD Clinical Care Guidelines for both type 1 and type 2 diabetes. She has served on many committees for both ISPAD and the ADA.  




  The ISPAD Prize of Achievement 2019 is supported by a grant from Eli Lilly

Contact Us

ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany


Click the link below to join the Society!

Join Today!

Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.or

Privacy Policy
Terms of Service
Legal Notice    


 © 2020 International Society for Pediatric and Adolescent Diabetes (ISPAD)

Association Management Software Powered by YourMembership  ::  Legal